日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A molecular signature of dormancy in CD34+CD38- acute myeloid leukaemia cells

CD34+CD38-急性髓系白血病细胞休眠的分子特征

Mazin Gh Al-Asadi, Grace Brindle, Marcos Castellanos, Sean T May, Ken I Mills, Nigel H Russell, Claire H Seedhouse, Monica Pallis

Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia

正常造血祖细胞亚群具有独特的活性氧、BCL2 和细胞周期特征,与急性髓系白血病的成熟无关

Naeem Khan, Robert K Hills, Steve Knapper, Lora Steadman, Ushna Qureshi, Jerrald L Rector, Charlotte Bradbury, Nigel H Russell, Paresh Vyas, Alan K Burnett, David Grimwade, Paul S Hole, Sylvie D Freeman

Targeting of CD34+CD38- cells using Gemtuzumab ozogamicin (Mylotarg) in combination with tipifarnib (Zarnestra) in Acute Myeloid Leukaemia

吉妥珠单抗 (Mylotarg) 与替比法尼 (Zarnestra) 联合用于治疗急性髓系白血病,靶向 CD34+CD38- 细胞

Mays Jawad, Ning Yu, Claire Seedhouse, Karuna Tandon, Nigel H Russell, Monica Pallis

P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA

用 aurora-B 激酶抑制剂 barasertib-hQPA 治疗的急性髓系白血病细胞中的 P-糖蛋白和乳腺癌耐药蛋白

Martin Grundy, Claire Seedhouse, Nigel H Russell, Monica Pallis